April 15, 2013
Timothy J. Schroeder, President and CEO of CTI Clinical Trial and Consulting Services (CTI) will present at Oracle’s 8th Annual Health Sciences Innovation Forum, taking place April 18, 2013 in Parsippany, New Jersey. The forum will explore and discuss the evolving requirements of the health sciences industry.
Mr. Schroeder will present on the topic Regenerative Medicine and Orphan Diseases-Critically Ill Patient Populations: Considerations for the Use of Oracle Argus Safety. “CTI has the unique experience of working with these complex patient populations that often pose special challenges, including enrollment and recruitment, trial size and power, subject retention and data integrity, and long-term safety assessment,” according to Timothy J. Schroeder. “Regenerative medicine and orphan diseases are increasingly important areas for clinical research, and it is necessary to have the highest standard of tools to manage these trials. CTI has been partnered with Oracle for more than ten years and utilizes their gold standard data management, safety, and clinical trial management systems.”
Mr. Schroeder founded CTI fourteen years ago, and is internationally recognized in the field of transplantation and regenerative medicine. During his 30 years in clinical, academic, and industry experience, he has authored more than 200 peer reviewed publications and has presented more than 300 papers at national and international conferences. He has served as a visiting lecturer on more than 200 occasions.